[Recombinant interferon alfa-2b in the treatment of patients with skin melanoma].
An analysis was performed of early and remote results of inauguration in patients with primary-circumscribed skin melanoma of extremities and trunk of adjuvant endolymphatic interferon therapy. The results showed a statistically insignificant tendency to improve as per comparison of indices for 3-yr survival. Comparative analysis of the above indices among male patients of the study group and controls revealed statistically significant augmentation of the survival index following postoperative interferon therapy.